News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Molina Healthcare (NYSE:MOH) and its peers.
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 25.1% over the past six months, topping the S&P 500 by 13.1 percentage points.
Oscar Health has surged 109% YTD as membership, revenue and expansion plans strengthen, though its price-to-book multiple tops the industry average.
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MOH's contract wins, acquisitions and cash generation support growth, but elevated medical costs and valuation pose risks.
Molina Healthcare event puts focus on growth, profitability mix Molina Healthcare (MOH) drew fresh attention after a recent screen highlighted its 7.3% annual revenue growth alongside a reported net loss, prompting investors to reassess how its scale in Medicaid and Medicare shapes the stock’s risk reward profile. Molina Healthcare’s share price has gained 12.2% over the past 90 days and 11.9% year to date, while the 1 year total shareholder return of 14.2% contrasts with weaker 3 and 5 year...
Molina Healthcare stock presents an interesting setup for valuation focused investors, with a 38.1% share price decline over the past three years sitting alongside a high value score and an undervalued read on market multiples. The share price is down 38.1% over the past three years, which raises the question of whether recent weakness has already priced in many of the concerns around the business. Stronger confidence in long term Medicaid funding can support higher earnings expectations for...
UnitedHealth, The Cigna, Humana, Centene and Molina have been highlighted in this Industry Outlook article.
An aging U.S. population, digital transformation, a diversified membership mix and strategic M&A are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.
LULU shares have fallen more than 40% this year, leaving the stock well below its recent highs.
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Burry Bets on Molina Healthcare's Long-Term Future Despite Near-Term Pressure
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
Older adults could be scrambling for new health coverage next year, especially in rural markets that have fewer insurance choices.
Molina Healthcare (NYSE:MOH) plans to significantly scale back its Affordable Care Act business from 2027. The company intends to limit ACA operations to six states and reduce premiums by a meaningful margin. The move follows ongoing pressure on ACA profitability, including falling membership and higher medical costs. Molina Healthcare, trading at $197.55, is restructuring its portfolio as it responds to challenges in the ACA segment. The stock is up 10.7% year to date and 19.7% over the...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina Healthcare (NYSE:MOH) reported second-quarter 2026 adjusted earnings per share of $1.51 on $10.2 billion of premium revenue, with management pointing to steady Medicaid performance and stronger-than-expected Medicare duals results while acknowledging continued pressure in its Marketplace busi
Molina Healthcare Inc (MOH) reports robust earnings and revenue growth, but faces hurdles in its Marketplace segment and regulatory pressures.
Moby summary of Molina Healthcare, Inc.'s Q2 2026 earnings call
Molina Healthcare (NYSE:MOH) shares dropped more than 9% in premarket trading on Thursday after the health insurer issued a full-year revenue outlook that disappointed investors, despite reporting second-quarter earnings ahead of market expectations. While profitability exceeded forecasts, concerns over slowing revenue growth and ongoing Medicaid headwinds weighed heavily on market sentiment.
The headline numbers for Molina (MOH) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
By Padmanabhan Ananthan July 22 (Reuters) - Molina Healthcare raised its annual profit forecast on Wednesday after posting second-quarter profit and revenue that beat Wall Street estimates, helped by
Molina (MOH) delivered earnings and revenue surprises of +10.22% and -0.08%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
The insurance company, which primarily operates through Medicare and Medicaid, said net income fell to $60 million due to lower premium revenue and an increase in the medical care ratio.
Molina healthcare has seen its stock edge down in recent days amid concerns about Medicaid cost pressures.